Yang Peng1, Bin Dong2, Zhiqiang Wang2. 1. Centre for Chronic Disease, School of Medicine, The University of Queensland, Herston, Australia. Electronic address: yang.peng@uq.net.au. 2. Centre for Chronic Disease, School of Medicine, The University of Queensland, Herston, Australia.
Abstract
BACKGROUND: The relationships between serum folate levels and all-cause, cardiovascular disease (CVD), and cancer mortality are controversial. METHODS: Utilizing 1999-2010 National Health and Nutrition Examination Survey (NHANES) and linked mortality data, we performed a cohort study with 28,845 participants and used Cox proportional hazards models and restricted cubic spline plots to elucidate the dose-response relationships between serum folate status and all-cause, CVD and cancer mortality. RESULTS: During an average follow-up for 6.2years, 2821, 545 and 628 deaths were attributed to all-causes, CVD and cancer, respectively. Lower folate levels were associated with increased mortality, with hazards ratios of 1.30 (95% confidence interval [CI]: 1.16-1.47) for all-cause mortality, 1.33 (95% CI: 1.01-1.76) for CVD mortality, and 1.47 (95% CI: 1.16-1.87) for cancer mortality (first quartiles versus second quartiles). A reversed J-shaped pattern was apparently observed in males and younger participants when analyzing all-cause mortality and in younger participants when it comes to CVD and cancer mortality. CONCLUSIONS: Lower folate levels, but not restricted to folate deficiency, are linked with higher rates of all-cause, CVD and cancer mortality. Adverse effects of excess folate as well as age and gender differences on mortality need further investigation.
BACKGROUND: The relationships between serum folate levels and all-cause, cardiovascular disease (CVD), and cancer mortality are controversial. METHODS: Utilizing 1999-2010 National Health and Nutrition Examination Survey (NHANES) and linked mortality data, we performed a cohort study with 28,845 participants and used Cox proportional hazards models and restricted cubic spline plots to elucidate the dose-response relationships between serum folate status and all-cause, CVD and cancer mortality. RESULTS: During an average follow-up for 6.2years, 2821, 545 and 628 deaths were attributed to all-causes, CVD and cancer, respectively. Lower folate levels were associated with increased mortality, with hazards ratios of 1.30 (95% confidence interval [CI]: 1.16-1.47) for all-cause mortality, 1.33 (95% CI: 1.01-1.76) for CVD mortality, and 1.47 (95% CI: 1.16-1.87) for cancer mortality (first quartiles versus second quartiles). A reversed J-shaped pattern was apparently observed in males and younger participants when analyzing all-cause mortality and in younger participants when it comes to CVD and cancer mortality. CONCLUSIONS: Lower folate levels, but not restricted to folate deficiency, are linked with higher rates of all-cause, CVD and cancer mortality. Adverse effects of excess folate as well as age and gender differences on mortality need further investigation.
Authors: Miranda J Spratlen; Maria Grau-Perez; Jason G Umans; Joseph Yracheta; Lyle G Best; Kevin Francesconi; Walter Goessler; Poojitha Balakrishnan; Shelley A Cole; Mary V Gamble; Barbara V Howard; Ana Navas-Acien Journal: Environ Int Date: 2018-10-12 Impact factor: 9.621
Authors: Pooja R Mandaviya; Roby Joehanes; Jennifer Brody; Juan E Castillo-Fernandez; Koen F Dekkers; Anh N Do; Mariaelisa Graff; Ismo K Hänninen; Toshiko Tanaka; Ester A L de Jonge; Jessica C Kiefte-de Jong; Devin M Absher; Stella Aslibekyan; Yolanda B de Rijke; Myriam Fornage; Dena G Hernandez; Mikko A Hurme; M Arfan Ikram; Paul F Jacques; Anne E Justice; Douglas P Kiel; Rozenn N Lemaitre; Michael M Mendelson; Vera Mikkilä; Ann Z Moore; Tess Pallister; Olli T Raitakari; Casper G Schalkwijk; Jin Sha; Eline P E Slagboom; Caren E Smith; Coen D A Stehouwer; Pei-Chien Tsai; André G Uitterlinden; Carla J H van der Kallen; Diana van Heemst; Donna K Arnett; Stefania Bandinelli; Jordana T Bell; Bastiaan T Heijmans; Terho Lehtimäki; Daniel Levy; Kari E North; Nona Sotoodehnia; Marleen M J van Greevenbroek; Joyce B J van Meurs; Sandra G Heil Journal: Am J Clin Nutr Date: 2019-08-01 Impact factor: 8.472
Authors: Tom Taverner; Francesca L Crowe; G Neil Thomas; Krishna Gokhale; Rasiah Thayakaran; Krishnarajah Nirantharakumar; Yusuf A Rajabally Journal: Nutrients Date: 2019-10-14 Impact factor: 5.717